Development of torcetrapib, a lipid-lowering drug, abandoned.
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use; D053480:Cholesterol Ester Transfer Proteins / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000187:drug effects; D006538:Heptanoic Acids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D006538:Heptanoic Acids; D011804:Quinolines